Archives of Cancer Science and Therapy, Год журнала: 2024, Номер 8(1), С. 054 - 062
Опубликована: Сен. 4, 2024
Background: The impact of COVID-19 and long-term on gastrointestinal neoplasms remains underexplored. current review investigates the potential link between these conditions role gut microbiota in mediating oncogenic processes. Dysbiosis, characterized by alterations microbial composition, may exacerbate inflammation immune dysregulation, contributing to cancer development. Methods: A comprehensive literature was conducted using databases including PubMed, Scopus, Embase, SciELO, Web Science. Inclusion criteria encompassed studies published 2020 2024 that explored intersection COVID-19, cancers. articles were critically appraised for quality relevance, data synthesized elucidate common mechanisms outcomes. Results: identifies several which influence risk patients. Persistent inflammation, oxidative stress, dysfunction observed Long COVID associated with dysbiosis. Specific metabolites, such as secondary bile short-chain fatty acids, implicated promoting tumorigenesis. Comparative analysis suggests SARS-CoV-2-induced dysbiosis heighten susceptibility cancers, particularly patients prolonged post-infection symptoms. Conclusion: findings underscore need further research clarify development among These could inform preventative strategies therapeutic interventions, those experiencing COVID. highlights gaps knowledge advocates longitudinal assess effects health.
Язык: Английский